12:00 AM
Aug 11, 2014
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Fate Therapeutics completes debt financing

Fate Therapeutics Inc. (NASDAQ:FATE), San Diego, Calif.
Business: Gene/Cell therapy, Cancer, Musculoskeletal
Date completed: 2014-07-31
Type: Debt financing
Raised: $10 million
Investor: Silicon Valley Bank

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >